Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
BACKGROUND: Highly active antiretroviral therapy (HAART) was introduced in 1997. We aimed to assess the continuing effect of this treatment on survival and progression to AIDS after HIV-1 seroconversion. METHODS: We used Cox models to estimate the effect of calendar year on time to AIDS and death i...
Autores principales: | , , , , , |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2003
|